#1 Clinical Trials Search in Europe

Isosorbide Dinitrate

Isosorbide Dinitrate (ISDN) is a medication that has been the subject of several clinical trials exploring its potential benefits in various cardiovascular conditions. These trials have investigated the use of ISDN in treating heart failure, acute coronary syndrome, pulmonary edema, and even in managing diabetic foot ulcers. The studies aim to evaluate the efficacy and safety of ISDN when used alone or in combination with other medications, providing valuable insights into its potential therapeutic applications.

Table of Contents

What is Isosorbide Dinitrate?

Isosorbide dinitrate is a medication that belongs to a class of drugs called nitrates. It’s commonly used to treat various heart and blood vessel conditions[1]. This drug is known by several brand names, including Isordil, Dilatrate-SR, and Sorbitrate[2].

How Does It Work?

Isosorbide dinitrate works as a vasodilator, which means it helps to widen (dilate) blood vessels. This action has effects on both arteries and veins in your body[3]. By widening blood vessels, isosorbide dinitrate can:

  • Improve blood flow to the heart
  • Reduce the workload on the heart
  • Lower blood pressure

These effects can help relieve symptoms associated with various heart conditions and improve overall heart function[1].

Medical Conditions Treated

Isosorbide dinitrate is used to treat several medical conditions, including:

  1. Heart Failure: This medication can help improve symptoms in patients with heart failure, a condition where the heart can’t pump blood effectively[1].
  2. Acute Coronary Syndrome: Isosorbide dinitrate may be used in the treatment of acute coronary syndrome, which includes conditions like unstable angina and heart attacks[4].
  3. Pulmonary Edema: This drug can help manage pulmonary edema, a condition where fluid accumulates in the lungs[5].
  4. Fontan Physiology: Research is being conducted on the use of isosorbide dinitrate in patients who have undergone the Fontan operation, a type of heart surgery[3].

Administration and Dosage

Isosorbide dinitrate can be administered in various forms, including:

  • Oral tablets or capsules
  • Intravenous (IV) injection
  • Spray form

The dosage and method of administration can vary depending on the specific condition being treated and the individual patient’s needs. For example:

  • In some heart failure studies, patients received 20mg to 40mg three times daily[1].
  • For acute coronary syndrome, a continuous intravenous infusion might be used[4].
  • In some cases, isosorbide dinitrate may be combined with other medications like hydralazine for enhanced effects[6].

Always follow your doctor’s instructions regarding dosage and administration.

Potential Side Effects

Like all medications, isosorbide dinitrate can cause side effects. Some potential side effects include:

  • Headaches
  • Dizziness
  • Low blood pressure (hypotension)
  • Fainting (syncope)

These side effects are often related to the medication’s blood vessel-widening effects. Your doctor will monitor you for these side effects and may adjust your dosage if needed[3].

Ongoing Research

Isosorbide dinitrate continues to be the subject of ongoing research to explore its potential benefits in various conditions:

  • Heart Failure in African Patients: Studies are investigating the effectiveness of isosorbide dinitrate combined with hydralazine in treating heart failure in African patients[6].
  • Diabetic Foot Ulcers: Research is exploring the potential benefits of isosorbide dinitrate spray combined with chitosan in treating diabetic foot ulcers[2].
  • Acute Decompensated Heart Failure: Studies are comparing the effectiveness of isosorbide dinitrate to other treatments like furosemide in managing acute decompensated heart failure[7].
  • Duchenne Muscular Dystrophy: Research is exploring the potential use of isosorbide dinitrate in combination with ibuprofen for treating Duchenne muscular dystrophy[8].

These ongoing studies highlight the continued interest in understanding and expanding the potential uses of isosorbide dinitrate in various medical conditions.

Condition Study Design Intervention Primary Outcome
Fontan Physiology Single arm trial Isosorbide Dinitrate (ISDN) titration Number of adverse reactions to ISDN
Heart Failure with Preserved Ejection Fraction Randomized, placebo-controlled ISDN alone or with hydralazine Change in wave reflection magnitude
Hypertensive Heart Failure Randomized, open-label ISDN and hydralazine Feasibility of recruitment
Acute Decompensated Heart Failure Randomized, single-blinded ISDN, furosemide, or combination Change in VAS dyspnea score
Acute Coronary Syndrome Randomized, open-label Intensive vs. standard blood pressure control with ISDN 1-year death rate and major cardiovascular events
Diabetic Foot Ulcers Randomized, double-blind ISDN spray with chitosan Histological changes in ulcers
Pulmonary Edema/Acute Heart Failure Randomized, double-blind ISDN, furosemide, or combination Days alive and out of hospital within 30 days

FAQ

  • What is Isosorbide Dinitrate used for in clinical trials? Isosorbide Dinitrate is being studied in clinical trials for various cardiovascular conditions, including heart failure, acute coronary syndrome, pulmonary edema, and even diabetic foot ulcers. It is often used as a vasodilator to improve blood flow and reduce strain on the heart.
  • How does Isosorbide Dinitrate work? Isosorbide Dinitrate is an organic nitrate that acts as a vasodilator. It works by relaxing blood vessels, which can help reduce blood pressure, improve blood flow, and decrease the workload on the heart.
  • Are there any side effects associated with Isosorbide Dinitrate in clinical trials? Common side effects observed in clinical trials include headaches, dizziness, and low blood pressure. Some studies also monitor for severe hypotension as a potential adverse effect.
  • Is Isosorbide Dinitrate being studied in combination with other medications? Yes, several clinical trials are investigating the use of Isosorbide Dinitrate in combination with other medications. For example, it is being studied in combination with hydralazine for heart failure treatment, and with furosemide for managing pulmonary edema.
  • What are some of the primary outcomes measured in these clinical trials? Primary outcomes vary depending on the specific condition being studied, but often include measures such as changes in symptoms (e.g., dyspnea relief), improvements in exercise capacity, reduction in mortality rates, and changes in various cardiovascular parameters like blood pressure and cardiac output.

Ongoing Clinical Trials on Isosorbide Dinitrate

  • Study on Sumatriptan and Rimegepant for Treating Nitroglycerin-Induced Headaches in Patients with Episodic Migraine

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Comparison of Furosemide, Nitrates, or Their Combination for Initial Treatment of Pulmonary Congestion in Patients with Acute Heart Failure

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark

  • Study on Hydralazine, Isosorbide Dinitrate, and Metformin for Patients with Chronic Heart Failure and Reduced Heart Function

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark

Glossary

  • Acute Decompensated Heart Failure (ADHF): A sudden worsening of heart failure symptoms, often requiring hospitalization. It is characterized by fluid buildup in the lungs and other parts of the body, causing difficulty breathing and swelling.
  • Vasodilator: A type of medication that widens blood vessels, improving blood flow and reducing blood pressure.
  • Pulmonary Edema: A condition where fluid accumulates in the air sacs of the lungs, making breathing difficult. It's often a complication of heart failure.
  • Ejection Fraction: A measurement of how much blood the left ventricle pumps out with each contraction. It's an important indicator of heart function.
  • Dyspnea: Difficulty breathing or shortness of breath, often experienced by patients with heart failure or pulmonary edema.
  • Cardiac Output: The amount of blood the heart pumps through the circulatory system in one minute.
  • Fontan Operation: A type of heart surgery used to treat some congenital heart defects, where the right ventricle is bypassed and venous blood flows directly to the lungs.
  • Bishop Score: A scoring system used to assess the readiness of the cervix for labor induction.
  • Visual Analogue Scale (VAS): A measurement instrument used to assess subjective characteristics or attitudes that cannot be directly measured, such as pain or dyspnea intensity.
  • Brain Natriuretic Peptide (BNP): A hormone released by the heart in response to changes in pressure inside the heart. It is often used as a marker for heart failure.

References

  1. https://clinicaltrials.gov/study/NCT01516346
  2. https://clinicaltrials.gov/study/NCT02789033
  3. https://clinicaltrials.gov/study/NCT04297241
  4. https://clinicaltrials.gov/study/NCT02135315
  5. https://clinicaltrials.eu/trial/study-on-furosemide-and-isosorbide-dinitrate-for-treating-pulmonary-congestion-in-acute-heart-failure-patients/
  6. https://clinicaltrials.gov/study/NCT01822808
  7. https://clinicaltrials.gov/study/NCT02649998
  8. https://clinicaltrials.gov/study/NCT01478022